Expression of KRAS and TP53 across Oncopig STS cell lines and leiomyosarcoma tumors. Expression of (a) total, (b) wild type (WT), and (c) mutant KRAS and TP53 in Oncopig primary fibroblasts, AdGFP treated fibroblasts, and STS cell lines. Expression of total, WT, and mutant (d) KRAS and (e) TP53 in Oncopig skeletal muscle and leiomyosarcomas (LMS). Samples represent biological replicates. Expression values are presented as fragments per kilobase of transcript per million fragments mapped (FPKM). *denotes p < 0.05, **denotes p < 0.01, ***denotes q < 0.05.